↓ Skip to main content

Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer

Overview of attention for article published in Frontiers in immunology, May 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
f1000
1 research highlight platform

Citations

dimensions_citation
95 Dimensions

Readers on

mendeley
91 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer
Published in
Frontiers in immunology, May 2019
DOI 10.3389/fimmu.2019.00954
Pubmed ID
Authors

Emily K. Kleczko, Jeff W. Kwak, Erin L. Schenk, Raphael A. Nemenoff

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 91 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 16 18%
Researcher 12 13%
Student > Master 9 10%
Student > Bachelor 5 5%
Other 4 4%
Other 10 11%
Unknown 35 38%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 17 19%
Immunology and Microbiology 10 11%
Agricultural and Biological Sciences 6 7%
Pharmacology, Toxicology and Pharmaceutical Science 6 7%
Medicine and Dentistry 4 4%
Other 7 8%
Unknown 41 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 November 2021.
All research outputs
#16,599,928
of 26,184,649 outputs
Outputs from Frontiers in immunology
#17,299
of 33,037 outputs
Outputs of similar age
#211,583
of 367,823 outputs
Outputs of similar age from Frontiers in immunology
#397
of 710 outputs
Altmetric has tracked 26,184,649 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 33,037 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 367,823 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 710 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.